I'd like to see a combination of the two. PPS stops BME and halts or slows Cartilage degradation while past stem cell therapies seem to have targeted cartilage regrowth. What is interesting is that the exec at PAR are ex-MSB, where this drug and its interaction with stem cells was studied. With PPS fast becoming the standard of care for knee OA wouldn't it be nice if they could prove better efficacy in combination with stem cells.
W
I'd like to see a combination of the two. PPS stops BME and...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $60.17M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 31.5¢ | $22.67K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7864 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.57pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
0.015 ( 4.76 %) |
||||
| Open | High | Low | Volume | ||
| 33.0¢ | 33.0¢ | 31.5¢ | 20409 | ||
| Last updated 15.48pm 31/05/2024 ? | |||||
| CYP (ASX) Chart |